P atients with SAH are at great risk for brain energy failure as a consequence of the initial insult and focal and/or systemic complications. The aneurysm rupture commonly causes an increase in intracerebral pressure leading to a brief period of brain circulatory arrest. In the subacute phase, vasospasm and/or increased ICP develop in most patients with SAH, potentially reducing cerebral blood flow and impairing energy metabolism. The humoral systemic stress response can induce cardiac, hemodynamic, and respiratory complications that further augment the mismatch between brain energy supply and demand. Therefore, SAH treatment protocols focus on increasing blood volume, blood pressure, and CPP to maintain sufficient cerebral blood flow.
extensively studied. Heuer et al. 2 have reported that an ICP > 20 mm Hg is common after SAH and correlates with a worse outcome; but because ICP varied with SAH severity, it did not independently predict outcome. Ryttlefors et al. 11 have recently shown that periods with ICPs > 20 mm Hg following SAH are associated with clinical deterioration, whereas periods with CPPs > 100 mm Hg are associated with clinical improvement. However, even an ICP of 15 mm Hg is above normal and can impair the brain microcirculation, especially during vasospasm. 18 When accepting ICP levels between 15-20 mm Hg, we may subject an already vulnerable brain to additional stress. One argument in favor of allowing relatively high ICP in patients with SAH is that aggressive CSF drainage can induce aneurysm rupture and/or worsen the consequences of a rebleeding-although once the aneurysm is repaired, the risk of a rebleed is eliminated.
Approximately 80% of the brain's energy metabolism is normally used for cycling Glt and Gln between neurones and astrocytes. 15 Interstitial Glt levels are kept low thanks to efficient uptake into astrocytes where Glt is converted to Gln. Glutamine is released back to the interstitial compartment where it is taken up by neurones and reconverted to Glt. Ischemia is associated with high interstitial Glt levels, which are believed to contribute to secondary damage and brain cell death. 20 Using intracerebral microdialysis in patients with SAH, we recently studied interstitial Glt and Gln levels in relation to ischemia, defined as increased lactate/pyruvate (L/P) ratios. Besides confirming a strong correlation between the L/P ratio and Glt, we found that brain interstitial Gln levels correlate with interstitial pyruvate levels, 13 suggesting that low pyruvate levels are accompanied by reduced Glt-Gln cycle activity. Increasing interstitial pyruvate levels have been associated with good recovery in patients with SAH 1 and may be a sign of improving glycolytic activity.
In the present study we wanted to explore the possible relationship among brain energy metabolism, the Glt-Gln cycle activity, and intracranial hemodynamics. Therefore, brain interstitial lactate, pyruvate, L/P ratio, Glt, Gln, and Gln/Glt ratio as well as ICP, CPP, and MABP were prospectively recorded in patients with spontaneous SAH.
Methods
The local ethics committee for human research approved this study. Informed consent to participate was obtained from all patients or their proxy.
Patient Population
Thirty-three patients-22 women and 11 men-with spontaneous SAH who had been admitted to the NICU at Uppsala University Hospital between April 2003 and September 2005 and who had undergone microdialysis monitoring were included in the study. The mean (± SD) patient age was 55.5 ± 8.9 years. The median World Federation of Neurosurgical Societies SAH grade 16 was III (range I-V). The aneurysms were treated surgically (16 patients) or with endovascular therapy (16 patients). In 1 patient no aneurysm was found. Either before or during treatment of the aneurysm, a microdialysis probe was placed in the frontal (30 patients) or temporal (3 patients) lobe cortex via a separate bur hole adjacent to a VD (28 patients) or through a bone flap (5 patients). Care was taken to insert the probe in what appeared to be uninjured cortex. The mean period from the first sign of SAH to the start of microdialysis sampling was 29.5 ± 24 hours, and the mean duration of sampling was 112 ± 37 hours. In our neurointensive care protocol, all patients with SAH follow a regimen of bed rest and nimodipine; the aim is to keep the patients normovolemic and normotensive. Patients with a decreased level of consciousness are intubated and receive ventilation to maintain normocapnia. All intubated patients are sedated with propofol and bolus doses of morphine. Muscle relaxants are used only during the intubation procedure. All patients had a VD for ICP monitoring and CSF drainage. We aim to keep ICP below 20 mm Hg and usually initiate CSF drainage at 15 mm Hg.
Since 1998 a networked, computerized multimodality monitoring system connected to a central server has been used to collect and store physiological data obtained in the Uppsala NICU. 5 One value per minute is displayed and saved for each channel and patient. Data collection is sometimes interrupted during radiological examinations or when a patient is taken to the operating theater. The data were manually validated, and the software was used to identify extreme values. 5 Negative ICP values were either removed or set to 0.
Microdialysis Monitoring
Intracerebral microdialysis was performed using CMA 70 probes with a 10-mm membrane length (CMA Microdialysis). The probes were perfused with artificial CSF (Na + 148 mmol/L, Ca
7 mmol/L, and Cl − 155 mmol/L) at a rate of 0.3 μl/minute by using a CMA 106 microinjection pump (CMA Microdialysis). Samples were taken hourly and analyzed at bedside for lactate, pyruvate, and urea with enzymatic techniques using a CMA 600 microdialysis analyzer (CMA Microdialysis). Urea was monitored to control the probe performance. 9 At least 3 hours passed between the insertion of the probe and the onset of sampling to allow for normalization of changes due to probe insertion. Quality controls at 2 different concentrations for each substance were performed every weekday. Imprecision values for between-assay coefficient of variation was < 10% for the low-concentration control sample and < 5% for the high-concentration control sample. Samples were analyzed for Glt and Gln using HPLC with fluorescence detection, as described in detail elsewhere.
samples were run together with each patient series. Imprecision values were 3-5% for the within-assay coefficient of variation and 5-9% for the between-assay coefficient of variation for the Glt and Gln measurements. Each hourly microdialysis sample was stamped with the time of collection. Because of dead space in the microdialysis tubing, which corresponded to a lag phase of 17 minutes, the dialysis fluid in a sample reflected the brain interstitial milieu during the period 17-77 minutes before the stamped collection time.
Recording the Clinical Course
Patient charts were retrospectively studied for information regarding the level of consciousness, level and volume of CSF drainage, fever episodes, cardiopulmonary problems, surgical procedures, extubations, and radiological examinations.
Statistical Analysis and Presentation of Data
Statistical analysis and graphical presentation were performed using Statistica, version 7.1. for Windows (StatSoft, Inc.). Results were regarded as significant if p < 0.05.
Each hourly microdialysis sample measurement was matched to the mean ICP, MABP, and CPP during the hour when the sample was collected. Parametric (Pearson linear) correlation analyses were performed to study the relationship between microdialysis data and pressure data. Correlation coefficients > 0.20 were considered to be of potential significance.
Microdialysis data were grouped depending on whether ICP was normal (≤ 10 mm Hg) or elevated (> 10 mm Hg). The 2 groups were compared and described using parametric and nonparametric statistics.
Results
In total, 3617 hours in the NICU were monitored using microdialysis and the computerized multimodality monitoring system. The ICP distribution during observation is presented in Fig. 1 . Cerebral perfusion pressure was positively correlated with Gln (r = 0.25; Fig. 2A) and pyruvate (r = 0.24; Fig. 2B ). Pyruvate was positively correlated with MABP (r = 0.23). Glutamine and the Gln/ Glt ratio were negatively correlated with ICP (r = −0.29 and −0.40; Fig. 2C ). Three of the 33 patients experienced high mean hourly ICPs in the 15-25 mm Hg range, and their clinical deterioration or lack of improvement was attributed to hydrocephalus and/or high ICP of another origin. None of them had severely pathological microdialysis patterns during the period when ICP was high; the L/P ratios were < 30 and Glt levels were < 15 μM. As a consequence of the high ICP, the VD was opened at 10 mm Hg in these 3 patients. Opening the drain and lowering the mean hourly ICP to 10 mm Hg were, in all cases, associated with interstitial Gln and pyruvate surges, which are illustrated in Fig. 3 .
Glutamine, Gln/Glt ratio, and pyruvate were significantly higher and Glt, lactate, and L/P ratio were significantly lower during ICP periods ≤ 10 mm Hg as compared with periods > 10 mm Hg (p < 0. 05; Table 1 ).
Discussion
We have recently reported that brain interstitial Glt increases and interstitial Gln decreases during periods of energy failure, defined as L/P ratios > 40 with low pyruvate levels, suggesting reduced Glt-Gln cycling due to a limited energy producing capacity. 13 During periods of high energy demand when there is increased glycolysis, defined as high interstitial lactate and pyruvate levels, interstitial Gln levels increase, which may indicate accelerated astrocytic Glt-Gln cycle activity in response to increased interstitial Glt levels. 1, 13 In the present study, we focused on the relationship between systemic pressure and ICP parameters and microdialysis variables related to energy metabolism and Glt turnover, following SAH. To our knowledge, this relationship has not been studied.
Glutamine and pyruvate were positively correlated with CPP. These variables increased over time and during the stay in the NICU. It is possible that increasing interstitial concentrations of pyruvate and Gln, which were observed in the majority of patients, 13 are a direct consequence of improved cerebral perfusion. The linear relationship among CPP, MABP, and pyruvate support the view that very high CPP can be beneficial following SAH, and these findings are consistent with recent work indicating that CPP > 100 mm Hg is associated with an improved or unaltered clinical course in SAH. 11 There was a negative correlation between Gln and ICP and an even stronger negative correlation between the Gln/Glt ratio and ICP. These findings support the notion that low interstitial Gln/Glt ratios are associated with brain tissue constraint, 8, 13 such as high ICP. Microdialysis patterns were generally significantly better (lower L/P ratio, lactate, and Glt and higher Gln, pyruvate, and Gln/ Glt ratio) when ICP was ≤ 10 mm Hg as compared with patterns during hours when ICP was > 10 mm Hg. The adverse effect of a high ICP on brain energy metabolism could be directly observed in 3 patients in whom CSF drainage was increased and ICP was lowered by opening the VD at 10 mm Hg (Fig. 3) . Lowering of the ICP was followed by a surge in interstitial Gln and pyruvate levels. We interpreted this microdialysis pattern as a sign of an energy metabolic boost on the alleviation of a constraint, which in these 3 cases appeared to be an unfavorably high ICP. The 3 cases illustrated that a moderately increased mean hourly ICP (15-25 mm Hg) appears to hamper brain tissue energy metabolism. It has been shown that patients with SAH who experience ICP > 20 mm Hg have higher mean Glt levels and L/P ratios as compared with patients without high ICP periods, 14 and that high ICP (> 20 mm Hg) periods are associated with clinical deterioration following SAH. 11 Data in the present study made us question whether patients with SAH and moderately elevated ICP (15-20 mm Hg) would benefit from CSF drainage at a lower pressure level than that stated in current clinical treatment protocols. The consistent pattern of pyruvate and Gln increases after lowering of the ICP also vividly illustrated the utility of microdialysis as a method for assessing treatment effects at the brain tissue level.
Brain interstitial Glt has been extensively studied, 4 but data on normal human brain interstitial Gln levels are scarce. In pediatric patients with traumatic brain injury 8 and adult NICU patients 10 in whom microdialysis setups similar to ours have been used, the highest Gln level was 572 and 1200 μM, respectively. In animals, basal brain interstitial Gln concentrations have ranged between 150 and 1000 μM. 6, 19 In view of these findings it appears that Gln levels > 1000 μM, which were present in a proportion of our cases ( Fig. 2A and C) , are elevated. In patients with FHP, increased brain Gln synthesis may play a role in brain edema formation by increasing the brain water content and ICP. In patients with FHP who experienced ICP levels above 20 mm Hg, brain interstitial Gln levels ranged from 700 to 10,000 μM (mean 6500 μM) when using a microdialysis setup similar to ours. 17 Interestingly, the lower Gln levels in that cohort overlapped with the higher Gln levels in our cohort with SAH. However, in FHP there was a positive correlation between Gln levels and ICP, whereas the correlation between ICP and Gln was negative in SAH.
We have characterized data from our patient cohort with respect to the interrelationship between various microdialysis variables; it was found that brain interstitial Gln correlates with pyruvate and that Gln levels increase during the NICU stay in most patients. 13 We have also observed surges in Gln and pyruvate following normalization of ischemic microdialysis patterns (high L/P ratio and high Glt) and during delayed ischemic neurological deteriorations. 12 In the present study, we reported on the occurrence of Gln surges and increasing pyruvate levels following the active lowering of ICP. Increasing Gln and pyruvate levels may be a favorable response in metabolically challenged tissue in which astrocytes try to maximize their glycolytic rate to yield adenosine 5′-triphosphate for the energy-demanding uptake of Glt. 
Conclusions
In this prospective observational NICU study, microdialysis data, ICP, CPP, and MABP were monitored during more than 3600 hours in 33 patients with SAH. The results showed that Gln and pyruvate levels correlate with CPP. Pyruvate correlates with MABP. Glutamine and the Gln/Glt ratio negatively correlate with ICP. According to collected microdialysis data, some patients appear to experience disturbed cerebral metabolism due to increased ICP at levels below the usual treatment thresholds. Periods with an ICP > 10 mm Hg were associated with a significantly worse microdialysis pattern, including lower Gln/Glt ratios and higher L/P ratios. Interstitial surges in Gln and pyruvate appeared in all cases in which a high ICP was treated with CSF drainage at 10 mm Hg.
We submit that alterations in the interstitial levels of Gln and pyruvate partly reflect the astrocytic metabolic activity. Increasing interstitial Gln and pyruvate levels af- ter a period of high ICP and/or low CPP appear to be a sign of a favorable energy metabolic situation allowing augmented astrocytic metabolism with accelerated Glt uptake and Gln synthesis. Finally, our findings support clinical treatment protocols targeting high CPP and low ICP in patients with SAH.
